Shanati Allah, Rivlin Yelena, Shnizer Sergei, Rosenschein Uri, Goldhammer Ehud
Allah Shanati, Yelena Rivlin, Sergei Shnizer, Uri Rosenschein, Ehud Goldhammer, Department of Cardiology and Cardiac Rehabilitation, Bnai Zion Medical Center, and the Faculty of Medicine, Technion, Haifa 31048, Israel.
World J Cardiol. 2009 Dec 31;1(1):46-50. doi: 10.4330/wjc.v1.i1.46.
To find out whether serum oxidizability potential correlates with exercise test (EXT) parameters and predicts their results in chronic ischemic heart disease (IHD) patients.
Oxidizability potential was determined in a group of chronic IHD patients who underwent a symptom limited EXT upon initiation of a cardiac rehabilitation program. The thermo-chemiluminescence (TCL) assay was used to assess serum oxidizability potential. This assay is based on heat-induced oxidation of serum, leading to the formation of electronically excited species in the form of unstable carbonyls, which further decompose into stable carbonyls and light energy (low chemiluminescence). Measured photons emission is represented by a kinetic curve which is described by its amplitude and slope (= ratio). We assessed the correlations of TCL ratio with exercise duration, metabolic equivalents (METS), maximal heart rate (mHR), maximal systolic BP, > 1 mm S-T depression, diabetes, hypertension, smoking, left ventricular ejection fraction (LVEF) > or < 40%, previous myocardial infarction, and aorto-coronary by-pass surgery and compared to the TCL ratio measured in a group of healthy controls.
A high TCL ratio (%) correlated well with METS (r = 0.84), with mHR (r = 0.79) and with exercise induced S-T segment shift (r = 0.87, P < 0.05). A lower serum oxidizability potential, expressed as a low TCL ratio, thus suggestive of a previous high oxidative stress, was found in IHD patients compared to healthy controls, and, in particular, in patients with low LVEF%. The TCL ratio (%) in IHD patients was 193 ± 21, compared to 215 ± 13 in controls (P < 0.05), and was 188 ± 14.7 in patients with LVEF < 40% as compared to 200 ± 11.9 in those with LVEF > 40% (P < 0.01). A trend for lower TCL ratio (%) was found in diabetic, hypertensive, and post-coronary bypass surgery patients. A paradoxically low TCL ratio (low oxidizability potential) was observed in patients without S-T depression compared to patients with S-T depression (189 ± 22 vs 201 ± 15, P = NS), due to the fact these patients had a much lower LVEF% and a lower exercise capacity.
Serum oxidizability potential is associated with EXT parameters, results, and IHD severity. TCL ratio is an "easy-to-measure marker" that might be incorporated into risk assessment and prediction in chronic IHD patients.
探究慢性缺血性心脏病(IHD)患者的血清氧化能力潜能是否与运动试验(EXT)参数相关,并预测其结果。
在一组慢性IHD患者中测定氧化能力潜能,这些患者在心脏康复计划开始时接受了症状限制性EXT。采用热化学发光(TCL)测定法评估血清氧化能力潜能。该测定法基于血清的热诱导氧化,导致形成不稳定羰基形式的电子激发态物质,其进一步分解为稳定羰基和光能(低化学发光)。测量的光子发射由一条动力学曲线表示,该曲线由其振幅和斜率(=比率)描述。我们评估了TCL比率与运动持续时间、代谢当量(METS)、最大心率(mHR)、最大收缩压、>1mm S-T段压低、糖尿病、高血压、吸烟、左心室射血分数(LVEF)>或<40%、既往心肌梗死以及主动脉冠状动脉搭桥手术之间的相关性,并与一组健康对照者测量的TCL比率进行比较。
高TCL比率(%)与METS(r = 0.84)、mHR(r = 0.79)以及运动诱发的S-T段移位(r = 0.87,P < 0.05)密切相关。与健康对照者相比,IHD患者的血清氧化能力潜能较低,表现为TCL比率较低,这提示先前存在较高的氧化应激,尤其是在LVEF%较低的患者中。IHD患者的TCL比率(%)为193±21,而对照组为215±13(P < 0.05);LVEF<40%的患者TCL比率为188±14.7,而LVEF>40%的患者为200±11.9(P < 0.01)。在糖尿病、高血压和冠状动脉搭桥手术后的患者中发现TCL比率(%)有降低趋势。与有S-T段压低的患者相比,无S-T段压低的患者观察到反常的低TCL比率(低氧化能力潜能)(189±22对201±15,P =无显著性差异),这是因为这些患者的LVEF%和运动能力低得多。
血清氧化能力潜能与EXT参数、结果及IHD严重程度相关。TCL比率是一个“易于测量的标志物”,可纳入慢性IHD患者的风险评估和预测中。